Endoscopic therapy of benign pyloric stenosis and gastric outlet obstruction.

Curr Opin Gastroenterol

GI Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.

Published: September 2006

Purpose Of Review: To examine the short and long-term success rates of balloon dilation of pyloric stenosis.

Recent Findings: Several large studies have demonstrated high rates of success for the relief of symptoms from pyloric stenosis using through-the-scope balloons. These dilating balloons readily increase the diameter of the stenotic pylorus on average from 6 to 16 mm. Patients who require more than two dilations are at high risk of endoscopic failure and the need for surgical intervention. Rapid re-stenosis rates are observed in patients with malignant pyloric obstruction. Since many patients with benign pyloric stenosis have underlying ulcer disease, helicobacter infection is a relatively common finding. Eradication of this infection at the time of balloon dilation will ensure higher long-term success rates.

Summary: In summary, benign pyloric stenosis can be readily treated with endoscopic balloon dilation and should be the first-line therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mog.0000239874.13867.41DOI Listing

Publication Analysis

Top Keywords

pyloric stenosis
16
benign pyloric
12
balloon dilation
12
long-term success
8
pyloric
6
endoscopic therapy
4
therapy benign
4
stenosis
4
stenosis gastric
4
gastric outlet
4

Similar Publications

Introduction: Congenital pyloric web or diaphragm are rare causes of Gastric Outlet Obstruction (GOO) after infancy, representing approximately 1 % of gastrointestinal obstructions. While it typically presents in the neonatal period with nonbilious vomiting, delayed diagnosis beyond infancy is exceptionally rare.

Presentation Of The Case: An 11-year-old girl with presented with one-month history of postprandial vomiting.

View Article and Find Full Text PDF

A rare pediatric case of type III congenital paraesophageal hiatal hernia with infantile hypertrophic pyloric stenosis: A case report.

Int J Surg Case Rep

January 2025

Department of Public Health and Infectious Diseases, Faculty of Medicine, Herat University, Herat, Afghanistan; Department of Epidemiology and Biostatistics, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Introduction: This case report presents a rare occurrence of Type III Congenital Paraesophageal Hiatal Hernia (CPEHH) with Infantile Hypertrophic Pyloric Stenosis (IHPS) in a 28-day-old neonate. However, this unusual combination poses significant diagnostic and surgical challenges.

Presentation Of Case: A 28-day-old male presented with respiratory distress and persistent vomiting.

View Article and Find Full Text PDF

Aim: To mine and analyze adverse drug events (ADEs) signals of azithromycin use in children in the real world to inform the safety assessment of azithromycin use in children.

Methods: ADE reports from the FDA Adverse Event Reporting System (FAERS) involving children (0-17 years) with azithromycin as the primary suspected drug from 2004 to early 2024 were extracted. ADEs were categorized using MedDRA, and signal detection was conducted using Reporting Odds Ratio (ROR) and Proportional Reporting Ratio (PRR).

View Article and Find Full Text PDF

Failure to thrive in infant secondary to congenital colonic stenosis: a case report.

J Surg Case Rep

December 2024

Department of Surgery, University of Miami, PO Box 016960 (C203), Miami, FL 33101, United States.

Congenital colonic stenosis (CCS) is a rare cause of intestinal obstruction, most commonly presenting in the neonatal period. We present a case of delayed CCS and describe the diagnostic challenges experienced. A 16-week-old female patient presented with persistent failure to thrive associated with signs of intestinal obstruction.

View Article and Find Full Text PDF
Article Synopsis
  • A 60s male patient diagnosed with advanced gastric cancer (with pyloric stenosis and enlarged lymph nodes) experienced significant tumor reduction after two courses of chemotherapy before surgery.
  • He underwent laparoscopic gastric jejunal bypass followed by distal gastrectomy and para-aortic lymph node dissection, with positive surgical results and no further tumor growth observed.
  • After the operation, he received a year of adjuvant chemotherapy and has remained recurrence-free for 1.5 years, highlighting the effectiveness of preoperative treatment for this condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!